SAM
Sectoral Asset Management Portfolio holdings
AUM
$151M
This Quarter Return
+0.25%
1 Year Return
+14.02%
3 Year Return
+79.35%
5 Year Return
+153.48%
10 Year Return
+511.68%
AUM
$520M
AUM Growth
+$520M
(+0.68%)
Cap. Flow
+$13.7M
Cap. Flow
% of AUM
2.64%
Top 10 Holdings %
Top 10 Hldgs %
23.77%
Holding
129
New
9
Increased
50
Reduced
34
Closed
11
Top Buys
| 1 |
Mineralys Therapeutics
MLYS
|
$9.6M |
| 2 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$5.08M |
| 3 |
TSVT
2seventy bio
TSVT
|
$4.86M |
| 4 |
Treace Medical Concepts
TMCI
|
$4.7M |
| 5 |
Vera Therapeutics
VERA
|
$4.66M |
Top Sells
| 1 |
Exelixis
EXEL
|
$8.88M |
| 2 |
RCM
R1 RCM Inc. Common Stock
RCM
|
$6.05M |
| 3 |
iRhythm Technologies
IRTC
|
$4.59M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$4.22M |
| 5 |
Arrowhead Research
ARWR
|
$3.87M |
Sector Composition
| 1 | Healthcare | 95.06% |
| 2 | Industrials | 4.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
126
Exelixis
EXEL
$9.95B
| – | – |
-553,475
| Closed | -$8.88M |
|
127
CRISPR Therapeutics
CRSP
$4.82B
| – | – |
-2,490
| Closed | -$101K |
|
128
BioXcel Therapeutics
BTAI
$52.7M
| – | – |
-61,156
| Closed | -$1.31M |
|
|
129
Arrowhead Research
ARWR
$3.84B
| – | – |
-95,400
| Closed | -$3.87M |
|